Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sergio Forero-Schwanhaeuser"'
Autor:
Lindsey Ingleby‐Talecki, Sven C. vanDijkman, Sean P. Oosterholt, Oscar Della Pasqua, Christina Winter, Marianne Cunnington, Linda Rebar, Sergio Forero‐Schwanhaeuser, Vickas Patel, James A. Cooper, Anthony Bahinski, Khuram W. Chaudhary
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 8, Pp 1978-1989 (2022)
Abstract Lamotrigine, approved for use as an antiseizure medication as well as the treatment of bipolar disorder, inhibits sodium channels in the brain to reduce repetitive neuronal firing and pathological release of glutamate. The shared homology of
Externí odkaz:
https://doaj.org/article/ffc94c4b636d4871bfe7eb3ce9458faa
Autor:
Jaime A. Davidson, Antonio Nino, Angela Jones-Leone, Timothy Wilson, Sergio Forero-Schwanhaeuser, Rickey R. Reinhardt
OBJECTIVE to evaluate the efficacy and safety of albiglutide compared with placebo and active comparators from an integrated trial subpopulation of Latino/Hispanic patients whose type 2 diabetes mellitus (T2DM) was inadequately controlled on their cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b0b2c1e539ec8295e95a59ff7e3f7e3
Publikováno v:
Postgraduate Medicine. 123:94-104
Antimuscarinics have proven efficacy as first-line therapy in overactive bladder (OAB); however, data on their use in older adults are needed.To assess the efficacy and tolerability of solifenacin in patients aged ≥ 65 years, we conducted post-hoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7e50373241311798a535cfe3fb02ab4
https://doi.org/10.3810/pgm.2011.01.2250
https://doi.org/10.3810/pgm.2011.01.2250
Autor:
Michael D. Vardy, Terri-Ann Samuels, Sergio Forero-Schwanhaeuser, Weizhong He, H. David Mitcheson
Publikováno v:
Female Pelvic Medicine & Reconstructive Surgery. 17:24-29
OBJECTIVE : To evaluate the efficacy of solifenacin versus placebo by baseline continence status using post hoc analysis. METHODS : Patients with overactive bladder (OAB) were randomized to solifenacin or placebo for 12 weeks; patient-reported outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75352c1b4f116d46b28c2fe20480a26
https://doi.org/10.1097/spv.0b013e3182042929
https://doi.org/10.1097/spv.0b013e3182042929
Publikováno v:
Current Medical Research and Opinion. 26:2277-2285
It is widely recognized that patient perception of overactive bladder (OAB) symptoms can vary considerably from mild to severe bother. This post hoc analysis reports outcomes in patients with severe OAB symptoms at baseline taken from the VESIcare Ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f65f2871449585ae625636ad1ee83ca9
https://doi.org/10.1185/03007995.2010.509582
https://doi.org/10.1185/03007995.2010.509582
Autor:
William D. Steers, Sergio Forero-Schwanhaeuser, Marc Gittelman, Masakazu Andoh, Steven A. Kaplan, Evan R Goldfischer
Publikováno v:
The Aging Male. 13:100-107
In the few studies to evaluate antimuscarinics for overactive bladder (OAB) in men, safety has been the primary focus. In OAB efficacy trials, subject populations have been predominantly female and patient-reported outcomes (PROs) have been assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87429ab3d59539b6790184f69c9ed5d5
https://doi.org/10.3109/13685530903440408
https://doi.org/10.3109/13685530903440408
Autor:
T. S. Marshall, Sergio Forero-Schwanhaeuser, Michael D. Vardy, J. D. Wegenke, W. He, H D Mitcheson, T.-A. Samuels
Publikováno v:
International Journal of Clinical Practice. 63:1702-1714
Summary Aim: The aim of this study was to evaluate the efficacy of solifenacin on symptom bother using the Overactive Bladder Questionnaire (OAB-q). Methods: In VIBRANT, a double-blind, US-based trial, patients with OAB for ≥ 3 months received flex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8532e34baddb211f7c55c0a6739b294d
https://doi.org/10.1111/j.1742-1241.2009.02209.x
https://doi.org/10.1111/j.1742-1241.2009.02209.x
Autor:
Indrani Nandy, Scott Serels, Christine Laramée, Marc R. Toglia, Raafat Seifeldin, Mickey M. Karram, Masakazu Andoh, Sergio Forero-Schwanhaeuser
Publikováno v:
Postgraduate Medicine. 121:151-158
Overactive bladder (OAB) is a prevalent, chronic condition that can negatively affect health-related quality of life (HRQL). Treatment goals are to improve symptoms and HRQL. We assessed the efficacy of solifenacin in OAB patients using several patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a623cb7d2ca9a8e623a826d3a1e7151a
https://doi.org/10.3810/pgm.2009.09.2062
https://doi.org/10.3810/pgm.2009.09.2062
Autor:
Sergio Forero-Schwanhaeuser, William D. Steers, Roger R. Dmochowski, Masakazu Andoh, Peter K. Sand
Publikováno v:
International Urogynecology Journal. 20:667-675
In overactive bladder (OAB), subjects' most bothersome symptom (MBS) may influence treatment-related outcomes. We evaluated effects of solifenacin on patient-reported outcomes (PROs) in subjects stratified by their MBS at baseline. In a 12-week, open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b7226b8f2a36f20a03e5254e1ff672
https://doi.org/10.1007/s00192-009-0840-y
https://doi.org/10.1007/s00192-009-0840-y
Autor:
Scott Serels, Masakazu Andoh, Mickey M. Karram, Allam Fakhoury, Marc R. Toglia, Sergio Forero-Schwanhaeuser
Publikováno v:
Urology. 73:14-18
Objectives In this double-blind, placebo-controlled trial, we assessed the efficacy and tolerability of solifenacin treatment for overactive bladder (OAB) with a focus on urgency-related endpoints. Changes in number of urgency episodes were evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14447d6639d6ce577f2d740ca2ab44e6
https://doi.org/10.1016/j.urology.2008.08.485
https://doi.org/10.1016/j.urology.2008.08.485